Delta 9 Receives Approval to List on TSX

DELTA 9 CANNABIS INC., a vertically integrated producer and seller of medical and retail use cannabis products (TSXV: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that its Securities (as defined below) will begin trading on the Toronto Stock Exchange (“TSX”) as of the opening of the market on September 3, 2019.

“With the increased visibility that trading on the TSX provides to the retail and institutional investor base, the up listing will help to increase trading liquidity and access a growing investor base interested in the cannabis industry,” said John Arbuthnot, founder and Chief Executive Officer of the Company.

Upon listing on the TSX, the Securities will continue to trade under the symbols “DN” for the common shares, “DN.WT.” for the common share purchase warrants expiring June 28, 2020, “DN.WT.A.” for the common share purchase warrants expiring July 17, 2022, and “DN.DB” for the 8.5% unsecured convertible debentures of the Company (collectively, the “Securities”). In conjunction with the listing on the TSX, the Securities will be voluntarily delisted from the TSX Venture Exchange prior to the commencement of trading on September 3, 2019.